Intra-Cellular Therapies (ITCI) Earnings Date, Estimates & Call Transcripts $126.20 -0.06 (-0.05%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Intra-Cellular Therapies Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 20Before Market OpensEstimatedActual EPS (Oct. 30) -$0.25 Missed By -$0.07 Consensus EPS (Oct. 30) -$0.18 Intra-Cellular Therapies released Q3 2024 earnings on October 30, 2024, reporting an EPS of -$0.25, which missed analysts' consensus estimates of -$0.18 by $0.07. Quarterly revenue rose 39.0% year-over-year to $175.40 million, above the consensus estimate of $172.30 million. With a trailing EPS of -$0.87, Intra-Cellular Therapies' earnings are expected to grow next year, from ($0.64) to $0.31 per share. Conference CallConference Call TranscriptITCI Upcoming EarningsIntra-Cellular Therapies' next earnings date is estimated for Thursday, February 20, 2025, based off prior year's reporting schedules. Get Intra-Cellular Therapies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intra-Cellular Therapies and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataITCI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ITCI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Intra-Cellular Therapies Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.64) EPSNext Year EPS Consensus Estimate: $0.31 EPS Intra-Cellular Therapies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/20/2025(Estimated)-------10/30/2024Q3 2024-$0.18-$0.25 -$0.07-$0.25$172.30M$175.40M8/7/2024Q2 2024-$0.19-$0.16+$0.03-$0.16$157.74M$161.40M5/7/2024Q1 2024-$0.31-$0.16+$0.15-$0.16$141.41M$144.90M2/22/2024Q4 2023-$0.44-$0.30+$0.14-$0.30$135.97M$132.10M11/2/2023Q3 2023-$0.59-$0.25+$0.34-$0.25$118.35M$126.17M8/3/2023Q2 2023-$0.62-$0.45+$0.17-$0.45$106.45M$110.80M5/4/2023Q1 2023-$0.63-$0.46+$0.17-$0.46$92.14M$95.31M3/1/2023Q4 2022-$0.62-$0.45+$0.17-$0.45$86.97M$87.87M Intra-Cellular Therapies Earnings - Frequently Asked Questions When is Intra-Cellular Therapies's earnings date? Intra-Cellular Therapies has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates. Learn more on ITCI's earnings history. Did Intra-Cellular Therapies beat their earnings estimates last quarter? In the previous quarter, Intra-Cellular Therapies (NASDAQ:ITCI) missed the analysts' consensus estimate of ($0.18) by $0.07 with a reported earnings per share (EPS) of ($0.25). Learn more on analysts' earnings estimate vs. ITCI's actual earnings. How can I listen to Intra-Cellular Therapies's earnings conference call? The conference call for Intra-Cellular Therapies's latest earnings report can be listened to online. Listen to Conference Call How can I read Intra-Cellular Therapies's conference call transcript? The conference call transcript for Intra-Cellular Therapies's latest earnings report can be read online. Read Transcript How much revenue does Intra-Cellular Therapies generate each year? Intra-Cellular Therapies (NASDAQ:ITCI) has a recorded annual revenue of $612.78 million. How much profit does Intra-Cellular Therapies generate each year? Intra-Cellular Therapies (NASDAQ:ITCI) has a recorded net income of -$139.67 million. ITCI has generated -$0.87 earnings per share over the last four quarters. What is Intra-Cellular Therapies's EPS forecast for next year? Intra-Cellular Therapies's earnings are expected to grow from ($0.64) per share to $0.31 per share in the next year. More Earnings Resources from MarketBeat Related Companies TAK Earnings ARGX Earnings BNTX Earnings TEVA Earnings BGNE Earnings GMAB Earnings VTRS Earnings SMMT Earnings MRNA Earnings RDY Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:ITCI) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intra-Cellular Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intra-Cellular Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
